File:Model retinoic acid extracellular signal-regulated kinase and Wnt pathway interactions.jpg: Difference between revisions

Revision as of 12:27, 31 August 2014

Model retinoic acid extracellular signal-regulated kinase and Wnt pathway interactions

A. Interaction between retinoic acid (RA) and the extracellular signal-regulated kinase (ERK) pathway during promoted neural specification. FGF receptor tyrosine kinase inhibitor SU5402 and MEK1/2 inhibitors PD184352 and PD0325901, respectively suppresses neural differentiation of ESCs. In RA-treated cultures, PD184352, PD0325901 and RARα-selective antagonist Ro 41–5253 could inhibit the neural specification of ESCs, while SU5402 shows weak neural inhibition effect. RA probably enhances ERK phosphorylation via MEK1/2 or its upstream but not in a manner that is dependent on FGF signaling, and activated ERK1/2 mediates phosphorylation of the MAPK sites of Smad1 (pSmad1MAPK), which inhibits the inhibitory function of the bone morphogenetic proteins (BMPs)-Smad1 pathway on neural differentiation. Blockade of RA signaling might affect the activation of the upstream of ERK1/2, which leads to failure of neural specification of ESCs even with the stimulation of FGF signaling.

B. Possible roles of Wnt signaling in RA-promoted neural differentiation. RA promotes neural specification probably by up-regulating Sfrp2, which inhibits the Wnt-β-catenin anti-neural pathway. Upon adding LiCl or CHIR99021, which stimulates the β-catenin signaling and/or BMP signaling through inhibition of GSK3, the suppression effects on neural specification of β-catenin pathway can be passed down even with the stimuli of RA. RA also may promote neural differentiation by up-regulating RAR, which may decrease β-catenin/LEF/TCF mediated transactivation. There exists a possibility that RA may suppress the inhibition effects on neural differentiation of Wnt-β-catenin pathway by sequestration of β-catenin. pSmad1GSK3 indicates phosphorylation of the GSK3 sites of Smad1.

extracellular signal-regulated kinase (ERK)

Links: Retinoic acid

Reference

Lu et al. BMC Cell Biology 2009 10:57 doi:10.1186/1471-2121-10-57

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Original file name: Figure 6. 1471-2121-10-57-6-l.jpg

File history

Yi efo/eka'e gwa ebo wo le nyangagi wuncin ye kamina wunga tinya nan

	Gwalagizhi	Nyangagi	Dimensions	User	Comment
current	17:10, 18 June 2011		1,000 × 323 (49 KB)	S8600021 (talk \| contribs)	==Model retinoic acid extracellular signal-regulated kinase and Wnt pathway interactions== A. Interaction between retinoic acid (RA) and the extracellular signal-regulated kinase (ERK) pathway during promoted neural specification. FGF receptor tyrosine k

You cannot overwrite this file.

File usage

The following page uses this file:

Developmental Signals - Retinoic acid

@@ Line 1: / Line 1: @@
 ==Model retinoic acid extracellular signal-regulated kinase and Wnt pathway interactions==
-A. Interaction between retinoic acid (RA) and the extracellular signal-regulated kinase (ERK) pathway during promoted neural specification. FGF receptor tyrosine kinase inhibitor SU5402 and MEK1/2 inhibitors PD184352 and PD0325901, respectively suppresses neural differentiation of ESCs. In RA-treated cultures, PD184352, PD0325901 and RARα-selective antagonist Ro 41–5253 could inhibit the neural specification of ESCs, while SU5402 shows weak neural inhibition effect. RA probably enhances ERK phosphorylation via MEK1/2 or its upstream but not in a manner that is dependent on FGF signaling, and activated ERK1/2 mediates phosphorylation of the MAPK sites of Smad1 (pSmad1MAPK), which inhibits the inhibitory function of the bone morphogenetic proteins (BMPs)-Smad1 pathway on neural differentiation. Blockade of RA signaling might affect the activation of the upstream of ERK1/2, which leads to failure of neural specification of ESCs even with the stimulation of FGF signaling.
+'''A.''' Interaction between retinoic acid (RA) and the extracellular signal-regulated kinase (ERK) pathway during promoted neural specification. FGF receptor tyrosine kinase inhibitor SU5402 and MEK1/2 inhibitors PD184352 and PD0325901, respectively suppresses neural differentiation of ESCs. In RA-treated cultures, PD184352, PD0325901 and RARα-selective antagonist Ro 41–5253 could inhibit the neural specification of ESCs, while SU5402 shows weak neural inhibition effect. RA probably enhances ERK phosphorylation via MEK1/2 or its upstream but not in a manner that is dependent on FGF signaling, and activated ERK1/2 mediates phosphorylation of the MAPK sites of Smad1 (pSmad1MAPK), which inhibits the inhibitory function of the bone morphogenetic proteins (BMPs)-Smad1 pathway on neural differentiation. Blockade of RA signaling might affect the activation of the upstream of ERK1/2, which leads to failure of neural specification of ESCs even with the stimulation of FGF signaling.
-B. Possible roles of Wnt signaling in RA-promoted neural differentiation. RA promotes neural specification probably by up-regulating Sfrp2, which inhibits the Wnt-β-catenin anti-neural pathway. Upon adding LiCl or CHIR99021, which stimulates the β-catenin signaling and/or BMP signaling through inhibition of GSK3, the suppression effects on neural specification of β-catenin pathway can be passed down even with the stimuli of RA. RA also may promote neural differentiation by up-regulating RAR, which may decrease β-catenin/LEF/TCF mediated transactivation. There exists a possibility that RA may suppress the inhibition effects on neural differentiation of Wnt-β-catenin pathway by sequestration of β-catenin. pSmad1GSK3 indicates phosphorylation of the GSK3 sites of Smad1.
+'''B.''' Possible roles of Wnt signaling in RA-promoted neural differentiation. RA promotes neural specification probably by up-regulating Sfrp2, which inhibits the Wnt-β-catenin anti-neural pathway. Upon adding LiCl or CHIR99021, which stimulates the β-catenin signaling and/or BMP signaling through inhibition of GSK3, the suppression effects on neural specification of β-catenin pathway can be passed down even with the stimuli of RA. RA also may promote neural differentiation by up-regulating RAR, which may decrease β-catenin/LEF/TCF mediated transactivation. There exists a possibility that RA may suppress the inhibition effects on neural differentiation of Wnt-β-catenin pathway by sequestration of β-catenin. pSmad1GSK3 indicates phosphorylation of the GSK3 sites of Smad1.
@@ Line 9: / Line 9: @@
-Original file name: Figure 6. 1471-2121-10-57-6-l.jpg
+:'''Links:''' [[Developmental_Signals_-_Retinoic_acid|Retinoic acid]]
 ===Reference===
@@ Line 21: / Line 21: @@
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
+Original file name: Figure 6. 1471-2121-10-57-6-l.jpg
+[[Category:Retinoic acid]]